Skip to main content

Our new intranet / wiki is online!

A new wiki/ intranet for the Cluster of Excellence ImmunoSensation is now available for our member:

https://confluence.team.uni-bonn.de/x/n4hWAQ

Thereby we use Confluence form the University of Bonn, where some Uni institutions (like the HRZ or Human Resources Development) with their areas can already be found.

In our new wiki / intranet information about our funding opportunities; Software and Hardware within the Cluster or important documentes for e.g. travel expenses can be found.

Access to Confluence is available to all employees with an Uni-ID.The access to the area for the cluster is limited, that means you will not see the area in the overview at the beginning.Confluence can be reached via eduroam/bonnet network or by using the Uni-VPN client.

Only after you have registered in the following form and we have activated your account you will have access to our area.

Registration: https://www.umfrageonline.com/s/d070df5

In the attachment you will find an FAQ with all relevant links and details about the requirements for usage as well as further information (for example contents of the area).

If you have any questions or feedback regarding our Confluence area, please feel free to contact us.We are happy if the new wiki is used a lot and we can encourage a good exchange!

Related news

Tracking glioblastoma cell spread in human brain tissue

Publication

Core2Edge: How tumor cells conquer the brain

—Glioblastoma is an aggressive brain tumor that infiltrates deep into the surrounding brain tissue. Even after surgery, tumor cells remain in the brain and the tumor recurs. Bonn researchers have now developed Core2Edge, a model based entirely on human tissue that captures these hard-to-access infiltration zones at the tumor margin. The model enables investigation of the invasive front and direct assessment of new drug candidates in human tissue - without the need for animal testing. The study of the Brain Tumor Translational Research Group has now been published in Nature Protocols.
View entry
Mikrochip zur Wiederherstellung zentralen Sehvermögens bei fortgeschrittener Makuladegeneration.

Publication

Approval of a Novel Retinal Implant Technology

—A novel retinal implant is offering people with geographic atrophy the opportunity to regain part of their central vision for the first time. Geographic atrophy is a severe late stage of age-related macular degeneration. An international research team led by Prof. Frank G. Holz of the UKB and the University of Bonn demonstrated in an international clinical trial that the majority of participants experienced significant improvements in visual acuity. The novel retinal implant technology has now received approval for routine clinical use in Europe, making it available beyond clinical trials.
View entry
Prof. Dr. Frank G. Holz – Director of the Department of Ophthalmology at the University Hospital Bonn (UKB) and Professor at the University of Bonn.

Honors & Funding

Frank Holz Nominated for the Science Breakthrough of the Year 2026

—A remarkable achievement for the Faculty of Medicine at the University of Bonn: Prof. Dr. Frank G. Holz, Director of the Department of Ophthalmology at the UKB and Professor at the University of Bonn, has been shortlisted for the Falling Walls Science Breakthrough of the Year 2026 in the Life Sciences category. His project is now among the 30 most outstanding scientific innovations worldwide in this category, recognized by the prestigious Falling Walls Science Summit. Being shortlisted alone represents a significant international distinction.
View entry

Back to the news overview